170 related articles for article (PubMed ID: 38401916)
1. Precision Oncology in Soft Tissue Sarcomas and Gastrointestinal Stromal Tumors.
Fontebasso AM; Rytlewski JD; Blay JY; Gladdy RA; Wilky BA
Surg Oncol Clin N Am; 2024 Apr; 33(2):387-408. PubMed ID: 38401916
[TBL] [Abstract][Full Text] [Related]
2. Role of genetic and molecular profiling in sarcomas.
Norberg SM; Movva S
Curr Treat Options Oncol; 2015 May; 16(5):24. PubMed ID: 25939540
[TBL] [Abstract][Full Text] [Related]
3. Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas.
Koseła-Paterczyk H; Rutkowski P
Expert Rev Anticancer Ther; 2017 Dec; 17(12):1107-1116. PubMed ID: 28988501
[TBL] [Abstract][Full Text] [Related]
4. Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours.
Mir O; Azaro A; Merchan J; Chugh R; Trent J; Rodon J; Ohnmacht U; Diener JT; Smith C; Yuen E; Oakley GJ; Le Cesne A; Soria JC; Benhadji KA; Massard C
Eur J Cancer; 2018 Nov; 103():88-97. PubMed ID: 30218977
[TBL] [Abstract][Full Text] [Related]
5. Molecular diagnostics in soft tissue sarcomas and gastrointestinal stromal tumors.
Smith SM; Coleman J; Bridge JA; Iwenofu OH
J Surg Oncol; 2015 Apr; 111(5):520-31. PubMed ID: 25772665
[TBL] [Abstract][Full Text] [Related]
6. Genomic Profiling and Clinical Outcomes of Targeted Therapies in Adult Patients with Soft Tissue Sarcomas.
Kokkali S; Georgaki E; Mandrakis G; Valverde C; Theocharis S
Cells; 2023 Nov; 12(22):. PubMed ID: 37998367
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and Molecular Characterization of Metastatic Gastrointestinal Stromal Tumors with Prolonged Benefit to Frontline Imatinib.
Serrano C; García-Del-Muro X; Valverde C; Sebio A; Durán J; Manzano A; Pajares I; Hindi N; Landolfi S; Jiménez L; Rubió-Casadevall J; Estival A; Lavernia J; Safont MJ; Pericay C; Díaz-Beveridge R; Martínez-Marín V; Vicente-Baz D; Vivancos A; Hernández-Losa J; Arribas J; Carles J
Oncologist; 2019 May; 24(5):680-687. PubMed ID: 30126859
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapy of cancer: new roles for pathologists in identifying GISTs and other sarcomas.
Antonescu CR
Mod Pathol; 2008 May; 21 Suppl 2():S31-6. PubMed ID: 18437171
[TBL] [Abstract][Full Text] [Related]
9. Relevant Trials Update in Sarcomas and Gastrointestinal Stromal Tumors: What Surgeons Should Know.
Callegaro D; Roland CL; Raut CP
Surg Oncol Clin N Am; 2022 Jul; 31(3):341-360. PubMed ID: 35715138
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal cells promote the drug resistance of gastrointestinal stromal tumors by activating the PI3K-AKT pathway via TGF-β2.
Zhao Y; Weng Z; Zhou X; Xu Z; Cao B; Wang B; Li J
J Transl Med; 2023 Mar; 21(1):219. PubMed ID: 36966336
[TBL] [Abstract][Full Text] [Related]
11. Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)
Casali PG; Le Cesne A; Velasco AP; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom H; Penel N; Hartmann JT; Duffaud F; Goldstein D; Martin-Broto J; Gronchi A; Wardelmann E; Marréaud S; Zalcberg JR; Litière S; Blay JY
Ann Oncol; 2021 Apr; 32(4):533-541. PubMed ID: 33482247
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapies in soft tissue sarcomas.
Judson I
Ann Oncol; 2010 Oct; 21 Suppl 7():vii277-80. PubMed ID: 20943628
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathobiology of gastrointestinal stromal sarcomas.
Corless CL; Heinrich MC
Annu Rev Pathol; 2008; 3():557-86. PubMed ID: 18039140
[TBL] [Abstract][Full Text] [Related]
14. The multifaceted landscape behind imatinib resistance in gastrointestinal stromal tumors (GISTs): A lesson from ripretinib.
Di Vito A; Ravegnini G; Gorini F; Aasen T; Serrano C; Benuzzi E; Coschina E; Monesmith S; Morroni F; Angelini S; Hrelia P
Pharmacol Ther; 2023 Aug; 248():108475. PubMed ID: 37302758
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of AKT-Signaling Sensitizes Soft Tissue Sarcomas (STS) and Gastrointestinal Stromal Tumors (GIST) to Doxorubicin via Targeting of Homology-Mediated DNA Repair.
Boichuk S; Bikinieva F; Nurgatina I; Dunaev P; Valeeva E; Aukhadieva A; Sabirov A; Galembikova A
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266502
[TBL] [Abstract][Full Text] [Related]
16. An Unexpected Response to Imatinib in a "Wild-Type" Gastrointestinal Stromal Tumor.
Gheysen M; Vander Borght S; Lehnert S; Vanslembrouck R; Vanden Bempt I; Schöffski P
Oncol Res Treat; 2020; 43(9):470-473. PubMed ID: 32640452
[TBL] [Abstract][Full Text] [Related]
17. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.
Demetri GD; Benjamin RS; Blanke CD; Blay JY; Casali P; Choi H; Corless CL; Debiec-Rychter M; DeMatteo RP; Ettinger DS; Fisher GA; Fletcher CD; Gronchi A; Hohenberger P; Hughes M; Joensuu H; Judson I; Le Cesne A; Maki RG; Morse M; Pappo AS; Pisters PW; Raut CP; Reichardt P; Tyler DS; Van den Abbeele AD; von Mehren M; Wayne JD; Zalcberg J;
J Natl Compr Canc Netw; 2007 Jul; 5 Suppl 2():S1-29; quiz S30. PubMed ID: 17624289
[TBL] [Abstract][Full Text] [Related]
18. [Molecular biology of sarcoma and therapeutic choices].
Dufresne A; Cassier P; Heudel P; Pissaloux D; Wang Q; Blay JY; Ray-Coquard I
Bull Cancer; 2015 Jan; 102(1):6-16. PubMed ID: 25609490
[TBL] [Abstract][Full Text] [Related]
19. Targeted therapy in sarcomas other than GIST tumors.
Sborov D; Chen JL
J Surg Oncol; 2015 Apr; 111(5):632-40. PubMed ID: 25330750
[TBL] [Abstract][Full Text] [Related]
20. Emerging drugs for the treatment of soft tissue sarcomas.
Cassier PA; Dufresne A; Fayette J; Alberti L; Ranchere D; Ray-Coquard I; Blay JY
Expert Opin Emerg Drugs; 2007 Mar; 12(1):139-53. PubMed ID: 17355219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
